Clinical Trial Update: Apixaban in Patients With Left Ventricular Thrombus [Phase 3]

View source ↗

Summary

Phase 3 trial update for apixaban in patients with left ventricular thrombus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Thrombus

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Saud Al Babtain Cardiac Center | Conditions: Left Ventricular Thrombus | Phase 3 | Status: COMPLETED